标题
SARS-CoV-2 Variants, Vaccines, and Host Immunity
作者
关键词
-
出版物
Frontiers in Immunology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-01-03
DOI
10.3389/fimmu.2021.809244
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Adaptive immunity to SARS-CoV-2 and COVID-19
- (2021) Alessandro Sette et al. CELL
- A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity
- (2021) Vincent Legros et al. Cellular & Molecular Immunology
- Genetic Variants of SARS-CoV-2—What Do They Mean?
- (2021) Adam S. Lauring et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Stabilizing the closed SARS-CoV-2 spike trimer
- (2021) Jarek Juraszek et al. Nature Communications
- A COVID-19 Vaccine: Big Strides Come with Big Challenges
- (2021) Juanita Mellet et al. Vaccines
- Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients
- (2021) Changqian Bao et al. Experimental Hematology & Oncology
- COVID-19 and the human innate immune system
- (2021) Joachim L. Schultze et al. CELL
- Maturation and persistence of the anti-SARS-CoV-2 memory B cell response
- (2021) Aurélien Sokal et al. CELL
- Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
- (2021) Wilfredo F. Garcia-Beltran et al. CELL
- Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera
- (2021) Daming Zhou et al. CELL
- SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
- (2021) Xiaoying Shen et al. Cell Host & Microbe
- Virus vaccines: proteins prefer prolines
- (2021) Rogier W. Sanders et al. Cell Host & Microbe
- Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
- (2021) Allison J. Greaney et al. Cell Host & Microbe
- In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2–Spike RBD Interface
- (2021) Bruno O. Villoutreix et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SARS-CoV-2 Viral Variants—Tackling a Moving Target
- (2021) John R. Mascola et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2
- (2021) Saman Saadat et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
- (2021) Nina Le Bert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Long term SARS-CoV-2 infectiousness among three immunocompromised patients: from prolonged viral shedding to SARS-CoV-2 superinfection
- (2021) Hassan Tarhini et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Understanding variants of SARS-CoV-2
- (2021) Talha Burki LANCET
- Monocytes and macrophages in COVID-19: Friends and foes
- (2021) Sepideh Meidaninikjeh et al. LIFE SCIENCES
- SARS-CoV-2 spike D614G change enhances replication and transmission
- (2021) Bin Zhou et al. NATURE
- How to redesign COVID vaccines so they protect against variants
- (2021) Ewen Callaway et al. NATURE
- Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein
- (2021) Houriiyah Tegally et al. NATURE
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
- (2021) Zijun Wang et al. NATURE
- SARS-CoV-2 evolution during treatment of chronic infection
- (2021) Steven A. Kemp et al. NATURE
- SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
- (2021) Constantinos Kurt Wibmer et al. NATURE MEDICINE
- Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
- (2021) Xuping Xie et al. NATURE MEDICINE
- Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
- (2021) Florian Krammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
- (2021) Nicholas G. Davies et al. SCIENCE
- Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera
- (2021) Alexander Muik et al. SCIENCE
- Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation
- (2021) Cecile King et al. TRENDS IN IMMUNOLOGY
- Discrete SARS-CoV-2 antibody titers track with functional humoral stability
- (2021) Yannic C. Bartsch et al. Nature Communications
- Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant
- (2021) Elisabeth Mahase BMJ-British Medical Journal
- The effect of spike mutations on SARS-CoV-2 neutralization
- (2021) Chloe Rees-Spear et al. Cell Reports
- Antibody Response After SARS-CoV-2 Infection and Implications for Immunity
- (2021) Irina Arkhipova-Jenkins et al. ANNALS OF INTERNAL MEDICINE
- SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
- (2021) Markus Hoffmann et al. CELL
- Antibody evasion by the P.1 strain of SARS-CoV-2
- (2021) Wanwisa Dejnirattisai et al. CELL
- SARS‐CoV‐2 Worldwide Replication Drives Rapid Rise and Selection of Mutations across the Viral Genome: A Time‐Course Study ‐ Potential Challenge for Vaccines and Therapies
- (2021) Stefanie Weber et al. EMBO Molecular Medicine
- Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February
- (2021) Daniel J Grint et al. Eurosurveillance
- Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection
- (2021) Salim S Abdool Karim LANCET
- Mix-and-match COVID vaccines trigger potent immune response
- (2021) Ewen Callaway NATURE
- Rare COVID reactions might hold key to variant-proof vaccines
- (2021) Ewen Callaway NATURE
- Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
- (2021) Erik Volz et al. NATURE
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
- (2021) Salim S. Abdool Karim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
- (2021) Nicole Doria-Rose et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
- (2021) Nuno R. Faria et al. SCIENCE
- Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil
- (2021) Ronaldo da Silva Francisco Jr et al. VIRUS RESEARCH
- IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
- (2021) Isabella Quinti et al. Frontiers in Cellular and Infection Microbiology
- The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
- (2021) Thomas P. Peacock et al. Nature Microbiology
- Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination
- (2021) Rishi R. Goel et al. Science Immunology
- Could Antigen Presenting Cells Represent a Protective Element during SARS-CoV-2 Infection in Children?
- (2021) Rita Lauro et al. Pathogens
- Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic
- (2021) Ben Jackson et al. CELL
- Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
- (2021) Chang Liu et al. CELL
- Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021
- (2021) Finlay Campbell et al. Eurosurveillance
- Neutralization of alpha, gamma, and D614G SARS‐CoV‐2 variants by CoronaVac vaccine‐induced antibodies
- (2021) Jorge Fernández et al. JOURNAL OF MEDICAL VIROLOGY
- Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin
- (2021) Pragya D Yadav et al. JOURNAL OF TRAVEL MEDICINE
- SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
- (2021) Aziz Sheikh et al. LANCET
- SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
- (2021) Jackson S. Turner et al. NATURE
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
- (2021) Jackson S. Turner et al. NATURE
- Broad sarbecovirus neutralization by a human monoclonal antibody
- (2021) M. Alejandra Tortorici et al. NATURE
- Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection
- (2021) Nikaïa Smith et al. NATURE IMMUNOLOGY
- A ‘mix and match’ approach to SARS-CoV-2 vaccination
- (2021) Meagan E. Deming et al. NATURE MEDICINE
- Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
- (2021) Emma Pritchard et al. NATURE MEDICINE
- A correlate of protection for SARS-CoV-2 vaccines is urgently needed
- (2021) Florian Krammer NATURE MEDICINE
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
- (2021) Yinon M. Bar-On et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
- (2021) Moriah Bergwerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Variants and Vaccines
- (2021) Philip R. Krause et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
- (2021) Stephen J. Thomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2: Possible recombination and emergence of potentially more virulent strains
- (2021) Dania Haddad et al. PLoS One
- Human IgG and IgA responses to COVID-19 mRNA vaccines
- (2021) Adam V. Wisnewski et al. PLoS One
- Optimized delay of the second COVID-19 vaccine dose reduces ICU admissions
- (2021) Paulo J. S. Silva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evidence for antibody as a protective correlate for COVID-19 vaccines
- (2021) Kristen A. Earle et al. VACCINE
- Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
- (2021) Satoshi Ikegame et al. Nature Communications
- Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
- (2021) Bo Meng et al. Cell Reports
- Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell
- (2021) Maritza Puray-Chavez et al. Cell Reports
- Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021
- (2021) Catherine M. Brown et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021
- (2021) Alyson M. Cavanaugh et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
- (2021) Renuka Raman et al. Biomolecules
- SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India
- (2021) Sarah Cherian et al. Microorganisms
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
- (2021) Sara Y Tartof et al. LANCET
- Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
- (2021) Shuo Feng et al. NATURE MEDICINE
- Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
- (2021) Koen B. Pouwels et al. NATURE MEDICINE
- mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
- (2021) Rishi R. Goel et al. SCIENCE
- Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021
- (2021) Anne M. Hause et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Structural Analysis of the SARS-CoV-2 Omicron Variant Proteins
- (2021) Qiangzhen Yang et al. Research
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
- (2020) Ahmet Kursat Azkur et al. ALLERGY
- A potential role for integrins in host cell entry by SARS-CoV-2
- (2020) Christian JA Sigrist et al. ANTIVIRAL RESEARCH
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Herd Immunity: Understanding COVID-19
- (2020) Haley E. Randolph et al. IMMUNITY
- COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
- (2020) Toshio Hirano et al. IMMUNITY
- Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients
- (2020) Peter D Burbelo et al. JOURNAL OF INFECTIOUS DISEASES
- Long‐term coexistence of SARS‐CoV‐2 with antibody response in COVID‐19 patients
- (2020) Bin Wang et al. JOURNAL OF MEDICAL VIROLOGY
- A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
- (2020) Markus Hoffmann et al. MOLECULAR CELL
- The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
- (2020) Linlin Bao et al. NATURE
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2
- (2020) Salvatore Di Giorgio et al. Science Advances
- Emergence of SARS-CoV-2 through recombination and strong purifying selection
- (2020) Xiaojun Li et al. Science Advances
- The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms
- (2020) Lo’ai Alanagreh et al. Pathogens
- Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding
- (2020) Tyler N. Starr et al. CELL
- The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
- (2020) Qianqian Li et al. CELL
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
- (2020) Bette Korber et al. CELL
- Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses
- (2020) Runhong Zhou et al. IMMUNITY
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals
- (2020) Davide F. Robbiani et al. NATURE
- Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
- (2020) Hongjing Gu et al. SCIENCE
- Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
- (2020) Ching-Lin Hsieh et al. SCIENCE
- Distinct conformational states of SARS-CoV-2 spike protein
- (2020) Yongfei Cai et al. SCIENCE
- Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
- (2020) Jose Mateus et al. SCIENCE
- Activation and evasion of type I interferon responses by SARS-CoV-2
- (2020) Xiaobo Lei et al. Nature Communications
- Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline
- (2020) Muhammad Abbas Abid et al. Frontiers in Immunology
- Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients
- (2020) Jae-Hoon Ko et al. Journal of Clinical Medicine
- Severe COVID-19 and aging: are monocytes the key?
- (2020) Brandt D. Pence GeroScience
- Innate and adaptive immune responses against coronavirus
- (2020) Arezoo Hosseini et al. BIOMEDICINE & PHARMACOTHERAPY
- COVID-19 Makes B Cells Forget, but T Cells Remember
- (2020) Pablo F. Cañete et al. CELL
- Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses
- (2020) Tania Gupta et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Naturally activated adaptive immunity in COVID‐19 patients
- (2020) Xiaofang Yang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
- (2020) Amin Addetia et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2
- (2020) Natacha S. Ogando et al. JOURNAL OF VIROLOGY
- Spike mutation D614G alters SARS-CoV-2 fitness
- (2020) Jessica A. Plante et al. NATURE
- Neuropilin-1 is a host factor for SARS-CoV-2 infection
- (2020) James L. Daly et al. SCIENCE
- Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
- (2020) Ludovico Cantuti-Castelvetri et al. SCIENCE
- Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses
- (2020) Patrick O’Connell et al. Human Vaccines & Immunotherapeutics
- The Immune Response and Immunopathology of COVID-19
- (2020) Esmaeil Mortaz et al. Frontiers in Immunology
- Covid-19: Perspectives on Innate Immune Evasion
- (2020) Nima Taefehshokr et al. Frontiers in Immunology
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
- (2020) Jeffrey Seow et al. Nature Microbiology
- Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
- (2020) Lauren B. Rodda et al. CELL
- Dynamic changes in monocytes subsets in COVID-19 patients
- (2020) Shuang Qin et al. HUMAN IMMUNOLOGY
- SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation
- (2020) Katlyn Lederer et al. IMMUNITY
- Neutrophils and COVID-19: The road so far
- (2020) Luiz Henrique Agra Cavalcante-Silva et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
- (2020) Bina Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection
- (2020) Michael W. Russell et al. Frontiers in Immunology
- Plasma Cells, the Next Generation: Beyond Antibody Secretion
- (2019) Peter D. Pioli Frontiers in Immunology
- CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker
- (2019) Alexandra Landras et al. Cancers
- Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 Is an Important Surface Attachment Factor That Facilitates Entry of Middle East Respiratory Syndrome Coronavirus
- (2016) Che-Man Chan et al. JOURNAL OF VIROLOGY
- Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
- (2016) Shuo Su et al. TRENDS IN MICROBIOLOGY
- T Follicular Helper Cell Differentiation, Function, and Roles in Disease
- (2014) Shane Crotty IMMUNITY
- Natural selection and infectious disease in human populations
- (2014) Elinor K. Karlsson et al. NATURE REVIEWS GENETICS
- Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research
- (2013) Graham Simmons et al. ANTIVIRAL RESEARCH
- Nomenclature for Immune Correlates of Protection After Vaccination
- (2012) S. A. Plotkin et al. CLINICAL INFECTIOUS DISEASES
- Coronaviruses
- (2011) Mark R. Denison et al. RNA Biology
- Adaptive immunity
- (2010) Francisco A. Bonilla et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Innate immune response to viral infection
- (2008) Shohei Koyama et al. CYTOKINE
- Mucins in the mucosal barrier to infection
- (2008) S K Linden et al. Mucosal Immunology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started